ES2107624T3 - Procedimiento de glucosilacion estereoselectivo. - Google Patents

Procedimiento de glucosilacion estereoselectivo.

Info

Publication number
ES2107624T3
ES2107624T3 ES93304817T ES93304817T ES2107624T3 ES 2107624 T3 ES2107624 T3 ES 2107624T3 ES 93304817 T ES93304817 T ES 93304817T ES 93304817 T ES93304817 T ES 93304817T ES 2107624 T3 ES2107624 T3 ES 2107624T3
Authority
ES
Spain
Prior art keywords
stereoselective
glucosilation
procedure
fluocarbohydrate
fluoronucleosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93304817T
Other languages
English (en)
Inventor
Ta-Sen Chou
Laurie Michelle Poteet
Douglas Patton Kjell
Cora Sue Grossman
Larry Wayne Hertel
Richard Elmer Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27583678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2107624(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/902,312 external-priority patent/US5371210A/en
Priority claimed from US08/044,312 external-priority patent/US5426183A/en
Priority claimed from US08/044,345 external-priority patent/US5594124A/en
Priority claimed from US08/044,343 external-priority patent/US5401838A/en
Priority claimed from US08/044,996 external-priority patent/US5821357A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2107624T3 publication Critical patent/ES2107624T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

UN PROCESO DE GLICOSILACION ESTEREOSELECTIVA PARA LA PREPARACION DE FLUORONUCLEOSIDOS CON (BETA) ANOMEROS MEDIANTE EL DESPLAZAMIENTO DE SN2 DE UN GRUPO SULFONILOXI ANOMERICO DE UN FLUOCARBOHIDRATO ENRIQUECIDO CON UN ANOMERO CON UNA NUCLEOBASE.
ES93304817T 1992-06-22 1993-06-21 Procedimiento de glucosilacion estereoselectivo. Expired - Lifetime ES2107624T3 (es)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US90230292A 1992-06-22 1992-06-22
US90215092A 1992-06-22 1992-06-22
US90213592A 1992-06-22 1992-06-22
US90231392A 1992-06-22 1992-06-22
US90211292A 1992-06-22 1992-06-22
US07/902,312 US5371210A (en) 1992-06-22 1992-06-22 Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US4430993A 1993-04-07 1993-04-07
US4431593A 1993-04-07 1993-04-07
US08/044,312 US5426183A (en) 1992-06-22 1993-04-07 Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US08/044,345 US5594124A (en) 1992-06-22 1993-04-07 Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US08/044,343 US5401838A (en) 1992-06-22 1993-04-07 Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US08/044,996 US5821357A (en) 1992-06-22 1993-04-07 Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides

Publications (1)

Publication Number Publication Date
ES2107624T3 true ES2107624T3 (es) 1997-12-01

Family

ID=27583678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93304817T Expired - Lifetime ES2107624T3 (es) 1992-06-22 1993-06-21 Procedimiento de glucosilacion estereoselectivo.

Country Status (20)

Country Link
EP (1) EP0577303B1 (es)
JP (1) JP3313191B2 (es)
KR (1) KR100252452B1 (es)
AT (1) ATE158799T1 (es)
BR (1) BR9302434A (es)
CA (1) CA2098881C (es)
CY (1) CY2067A (es)
DE (1) DE69314239C5 (es)
DK (1) DK0577303T3 (es)
ES (1) ES2107624T3 (es)
FI (1) FI108643B (es)
GR (1) GR3025689T3 (es)
HU (2) HUT64358A (es)
IL (1) IL106071A (es)
MX (1) MX9303707A (es)
MY (1) MY115775A (es)
NO (1) NO180235B3 (es)
NZ (1) NZ247939A (es)
PL (1) PL172348B1 (es)
UA (1) UA41261C2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
JP2000501738A (ja) 1995-12-13 2000-02-15 イーライ・リリー・アンド・カンパニー α,α―ジフルオロ―β―ヒドロキシチオールエステル及びその合成
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
AU3851601A (en) * 2000-02-18 2001-08-27 Southern Res Inst Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-9h- purin-6-amine
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
US6680382B2 (en) * 2001-08-02 2004-01-20 Ilex Products, Inc. Process for preparing purine nucleosides
US7176237B2 (en) 2002-01-15 2007-02-13 The Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
US6884880B2 (en) * 2002-08-21 2005-04-26 Ash Stevens, Inc. Process for the preparation of 9-β-anomeric nucleoside analogs
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN100384862C (zh) * 2003-05-22 2008-04-30 独立行政法人科学技术振兴机构 α-选择性糖基化反应方法
WO2006070985A1 (en) 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
KR20070112774A (ko) * 2005-03-04 2007-11-27 다브르 파마 리미티드 베타―아노머가 많은21데옥시,21,21-디플루오로-d-리보푸라노실뉴클레오시드의 제조를 위한 중간체 및 제조 방법
CA2610283C (en) * 2005-06-03 2011-08-30 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’,2’-二氟-胞苷合成的方法
US8299046B2 (en) 2006-11-17 2012-10-30 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process
CN100475832C (zh) 2007-05-31 2009-04-08 南京卡文迪许生物工程技术有限公司 一种新颖的高立体选择性合成吉西他滨工艺及中间体
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
BRPI0907423A2 (pt) 2008-01-11 2020-10-27 Reata Pharmaceuticals, Inc. composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto
JP5529851B2 (ja) 2008-04-18 2014-06-25 リアタ ファーマシューティカルズ インコーポレイテッド 抗酸化炎症モジュレーター:c−17においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
KR101713140B1 (ko) 2008-04-18 2017-03-08 리타 파마슈티컬스 잉크. C-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
WO2009146218A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
MX2010011439A (es) 2008-04-18 2011-01-25 Reata Pharmaceuticals Inc Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17.
CN108686203A (zh) 2012-04-04 2018-10-23 哈洛齐梅公司 使用抗透明质酸剂和肿瘤靶向紫杉烷的组合疗法
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
JP6431520B2 (ja) * 2013-03-15 2018-11-28 エピジェネティクス・ファーマ・エルエルシー フッ化ピリミジン類縁体及びその使用方法
WO2018200859A1 (en) 2017-04-26 2018-11-01 Kalman Thomas I Multitargeted nucleoside derivatives
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
ES2157289T3 (es) * 1987-08-28 2001-08-16 Lilly Co Eli Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc 2’−デオキシ−β−アデノシンの製造方法
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
WO1991015498A2 (en) * 1990-04-04 1991-10-17 Nycomed Imaging As Nucleoside derivatives
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides

Also Published As

Publication number Publication date
JP3313191B2 (ja) 2002-08-12
NO932288A (no) 1993-12-23
HU223837B1 (hu) 2005-02-28
DE69314239D1 (de) 1997-11-06
MX9303707A (es) 1994-06-30
DE69314239C5 (de) 2012-11-29
EP0577303A1 (en) 1994-01-05
IL106071A (en) 2006-08-20
IL106071A0 (en) 1993-10-20
KR100252452B1 (en) 2000-04-15
MY115775A (en) 2003-09-30
FI932869L (fi) 1993-12-23
CA2098881A1 (en) 1993-12-23
ATE158799T1 (de) 1997-10-15
PL299415A1 (en) 1994-03-07
DE69314239T2 (de) 1998-02-19
FI108643B (fi) 2002-02-28
HU0201196D0 (es) 2002-06-29
PL172348B1 (pl) 1997-09-30
UA41261C2 (uk) 2001-09-17
GR3025689T3 (en) 1998-03-31
BR9302434A (pt) 1994-02-16
NO180235B (no) 1996-12-02
EP0577303B1 (en) 1997-10-01
CA2098881C (en) 2005-06-07
JPH06157570A (ja) 1994-06-03
NZ247939A (en) 1996-02-27
DK0577303T3 (da) 1997-10-27
HUT64358A (en) 1993-12-28
NO932288D0 (no) 1993-06-21
NO180235B3 (no) 2007-10-01
KR940005658A (ko) 1994-03-22
FI932869A0 (fi) 1993-06-21
HU9301822D0 (en) 1993-09-28
CY2067A (en) 1993-06-21
NO180235C (no) 1997-03-12

Similar Documents

Publication Publication Date Title
ES2107624T3 (es) Procedimiento de glucosilacion estereoselectivo.
IT8521847A0 (it) Procedimento ed impianto per produrre tubi senza saldature.
DE3886381D1 (de) Zufuhrsystem für gereinigtes wasser.
IT8820190A0 (it) Pilone per aereo.
IT8721512A0 (it) Processo per la preparazione di2,2,6,6 tetrametil 4piperidilammine.
DE3783876D1 (de) Tdma-uebertragungssystem mit gemeinsamen zeitschlitzen fuer systemwartung.
ES2023976B3 (es) Procedimiento para el enriquecimiento de helio.
ES2023977B3 (es) Procedimiento para la obtencion de helio.
EP0331753A4 (en) METHOD FOR PRODUCING ORGANOPOLYSILOXANES WITH AN ALKENYL END GROUP.
FI884720A0 (fi) Kompositioner foer anvaendning som kontrastmedel.
MX9204521A (es) Proceso para la preparacion de natamicina por fermentacion (caso ch-1898).
IT1227997B (it) Piegatrice per tubi.
BR9304843A (pt) Cultura biologicamente pura do microorganismo de streptomyces avermitilis, processo para produzir pelo menos um composto de avermectina e avermectina assim produzida, processo para produzir ivermectina e ivermectina assim produzida.
GB2200062B (en) Apparatus for bending tubes.
MX9204520A (es) Proceso para la preparacion de natamicina por fermentacion (caso ch 2074).
GR862242B (en) Method for preparing (+) -6-chloro-5,10-dihydro-5-((1-methyl-4-piperidinyl) acetyl)-11h-dibenzo (b,e) (1,4) diazepin -11-on
IT8721108A0 (it) Procedimento per la selezione di tubetti.
IT8722847A0 (it) Processo per la preparazione di lattolosio da lattosio mediante epimerizzazione con alluminato sodico
DE3866895D1 (de) Farbkathodenstrahlroehre.
HUT47645A (en) Process for producing 1-methyl-1,4-androstadien-3,17-dione
IT1163505B (it) Processo per la preparazione di 3,3' - o 3,4' -diamminobenzofenone
IT8321577A0 (it) Processo per la preparazione di 3,3' - o 3,4' diammino-difenilmetano.
AU2321188A (en) Process for producing organopolysiloxanes having alkenyl group at its end
IL102144A0 (en) Process for producing 2'-deoxy-2',2'-difluoro nucleosides
GR3030314T3 (en) Process for selectively isolating bêta-2'-deoxy-2',2'-difluorocytidine or its salts.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 577303

Country of ref document: ES